AVIDITY BIOSCIENCES INC's ticker is RNA and the CUSIP is 05370A108. A total of 148 filers reported holding AVIDITY BIOSCIENCES INC in Q4 2022. The put-call ratio across all filers is 1.20 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,085,396 | -43.5% | 640,344 | -1.7% | 0.00% | 0.0% |
| Q2 2023 | $7,225,134 | -21.7% | 651,500 | +8.3% | 0.00% | -50.0% |
| Q1 2023 | $9,231,597 | -21.2% | 601,407 | +13.9% | 0.00% | 0.0% |
| Q4 2022 | $11,713,102 | +49.1% | 527,855 | +9.8% | 0.00% | 0.0% |
| Q3 2022 | $7,854,000 | +18.3% | 480,908 | +5.3% | 0.00% | +100.0% |
| Q2 2022 | $6,639,000 | -3.7% | 456,914 | +22.4% | 0.00% | 0.0% |
| Q1 2022 | $6,897,000 | -23.5% | 373,394 | -1.5% | 0.00% | 0.0% |
| Q4 2021 | $9,014,000 | +3.0% | 379,241 | +6.8% | 0.00% | -50.0% |
| Q3 2021 | $8,749,000 | +30.5% | 355,230 | +31.0% | 0.00% | +100.0% |
| Q2 2021 | $6,704,000 | +6.9% | 271,270 | -5.7% | 0.00% | 0.0% |
| Q1 2021 | $6,274,000 | +27.9% | 287,679 | +49.7% | 0.00% | 0.0% |
| Q4 2020 | $4,905,000 | -9.9% | 192,223 | -0.6% | 0.00% | 0.0% |
| Q3 2020 | $5,445,000 | – | 193,427 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 907,567 | $22,353,000 | 19.68% |
| 5AM Venture Management, LLC | 555,555 | $13,683,000 | 2.78% |
| Octagon Capital Advisors LP | 446,641 | $11,001,000 | 2.71% |
| EcoR1 Capital, LLC | 2,759,505 | $67,967,000 | 2.36% |
| Cormorant Asset Management, LP | 2,162,115 | $53,253,000 | 2.16% |
| Asymmetry Capital Management, L.P. | 126,116 | $3,106,000 | 1.87% |
| RTW INVESTMENTS, LP | 4,795,000 | $118,101,000 | 1.78% |
| Aaron Wealth Advisors LLC | 229,595 | $5,654,000 | 1.59% |
| Altium Capital Management LP | 225,000 | $5,542,000 | 1.45% |
| Boxer Capital, LLC | 1,121,327 | $27,618,000 | 0.96% |